scispace - formally typeset
Open AccessJournal Article

Effects of quinidine on the renal tubular and biliary transport of digoxin: in vivo and in vitro studies in the dog.

Reads0
Chats0
TLDR
It is concluded that quinidine inhibits the renal excretion of digoxin not by competition at the tubular cell membrane level, but rather by decreasing renal blood flow.
Abstract
Quinidine is known to inhibit the renal clearance of digoxin without affecting glomerular filtration rate. The renal interaction between these drugs was investigated by a combination of in vivo and in vitro methods. The uptake of digoxin by brush border membrane vesicles was not affected by quinidine. Similarly, digoxin did not inhibit the uptake of the cation N-methylnicotinamide by these vesicles and did not alter the binding kinetics of digoxin to the Na+, K+-adenosine triphosphatase by the antiluminal membrane vesicles. By using the in vivo multiple indicator dilution technique transtubular transport of digoxin was documented; renal-artery infusion of quinidine did not affect the recovery of digoxin in the renal vein or urine. Clearance studies documented that the decrease in the renal clearance of digoxin is paralleled by a significant fall in renal blood flow evidenced by a decrease in p-aminohippuric acid clearance. It is concluded that quinidine inhibits the renal excretion of digoxin not by competition at the tubular cell membrane level, but rather by decreasing renal blood flow. A parallel decrease in biliary clearance of digoxin is documented and may suggest a similar mechanism.

read more

Citations
More filters
Journal ArticleDOI

The MDR1 gene product, P-glycoprotein, mediates the transport of the cardiac glycoside, digoxin.

TL;DR: The present studies implicate P-glycoprotein, the MDR1 gene product overexpressed in multidrug resistant cells, as the apical membrane protein responsible for the renal secretion of digoxin and provide an explanation for the occurrence ofdigoxin toxicity in the presence of certain co-administered medications.
Journal ArticleDOI

Substantial pharmacokinetic interaction between digoxin and ritonavir in healthy volunteers

TL;DR: The effect of repetitive ritonavir administration on digoxin distribution and total and renal digoxin clearance as a marker for P‐gp activity in vivo is assessed.
Journal ArticleDOI

Transporter-mediated drug-drug interactions.

TL;DR: This article focuses on probe drugs lacking significant metabolism to highlight mechanisms of interactions of selected intestinal, hepatic and renal drug transporters and Genotype-dependent drug-drug interactions are discussed.
Journal ArticleDOI

Hepatobiliary excretion of berberine.

TL;DR: Berberine displays a linear pharmacokinetic phenomenon in the dosage range from 10 to 20 mg kg(-1), since a proportional increase in the area under the concentration-time curve (AUC) of berberine was observed in this dosage range.
Journal ArticleDOI

Transporter-mediated Drug Interactions.

TL;DR: This review deals with recent progress in molecular and functional research on drug transporters, and then with transporter-mediated drug interactions in absorption and secretion fromThe intestine, secretion from the kidney and liver, and transport across the blood-brain barrier in humans.
Related Papers (5)